BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 16794633)

  • 1. Nucleophosmin and cancer.
    Grisendi S; Mecucci C; Falini B; Pandolfi PP
    Nat Rev Cancer; 2006 Jul; 6(7):493-505. PubMed ID: 16794633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of nucleophosmin in embryonic development and tumorigenesis.
    Grisendi S; Bernardi R; Rossi M; Cheng K; Khandker L; Manova K; Pandolfi PP
    Nature; 2005 Sep; 437(7055):147-53. PubMed ID: 16007073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of nucleophosmin 1 (NPM1) gene mutations in common solid cancers.
    Jeong EG; Lee SH; Yoo NJ; Lee SH
    APMIS; 2007 Apr; 115(4):341-6. PubMed ID: 17504301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleophosmin: from structure and function to disease development.
    Box JK; Paquet N; Adams MN; Boucher D; Bolderson E; O'Byrne KJ; Richard DJ
    BMC Mol Biol; 2016 Aug; 17(1):19. PubMed ID: 27553022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The leukemia-associated cytoplasmic nucleophosmin mutant is an oncogene with paradoxical functions: Arf inactivation and induction of cellular senescence.
    Cheng K; Grisendi S; Clohessy JG; Majid S; Bernardi R; Sportoletti P; Pandolfi PP
    Oncogene; 2007 Nov; 26(53):7391-400. PubMed ID: 17546053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Born to be exported: COOH-terminal nuclear export signals of different strength ensure cytoplasmic accumulation of nucleophosmin leukemic mutants.
    Bolli N; Nicoletti I; De Marco MF; Bigerna B; Pucciarini A; Mannucci R; Martelli MP; Liso A; Mecucci C; Fabbiano F; Martelli MF; Henderson BR; Falini B
    Cancer Res; 2007 Jul; 67(13):6230-7. PubMed ID: 17616680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of nucleophosmin in acute myeloid leukemia.
    Meani N; Alcalay M
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1283-94. PubMed ID: 19761432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice.
    Falini B; Martelli MP; Mecucci C; Liso A; Bolli N; Bigerna B; Pucciarini A; Pileri S; Meloni G; Martelli MF; Haferlach T; Schnittger S
    Haematologica; 2008 May; 93(5):775-9. PubMed ID: 18367491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic role of nucleophosmin/B23.
    Yung BY
    Chang Gung Med J; 2007; 30(4):285-93. PubMed ID: 17939258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleophosmin and its complex network: a possible therapeutic target in hematological diseases.
    Colombo E; Alcalay M; Pelicci PG
    Oncogene; 2011 Jun; 30(23):2595-609. PubMed ID: 21278791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of exon 12 type A mutation of NPM1 gene in IMS-M2 cell line.
    Chi HT; Vu HA; Iwasaki R; Nagamura F; Tojo A; Watanabe T; Sato Y
    Leuk Res; 2010 Feb; 34(2):261-2. PubMed ID: 19854508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleophosmin in leukemia: Consequences of anchor loss.
    Brodská B; Šašinková M; Kuželová K
    Int J Biochem Cell Biol; 2019 Jun; 111():52-62. PubMed ID: 31009764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA aptamers interfering with nucleophosmin oligomerization induce apoptosis of cancer cells.
    Jian Y; Gao Z; Sun J; Shen Q; Feng F; Jing Y; Yang C
    Oncogene; 2009 Nov; 28(47):4201-11. PubMed ID: 19734942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NSC348884, a nucleophosmin inhibitor disrupts oligomer formation and induces apoptosis in human cancer cells.
    Qi W; Shakalya K; Stejskal A; Goldman A; Beeck S; Cooke L; Mahadevan D
    Oncogene; 2008 Jul; 27(30):4210-20. PubMed ID: 18345031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rb loss causes cancer by driving mitosis mad.
    van Deursen JM
    Cancer Cell; 2007 Jan; 11(1):1-3. PubMed ID: 17222786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SMT3IP1, a nucleolar SUMO-specific protease, deconjugates SUMO-2 from nucleolar and cytoplasmic nucleophosmin.
    Nishida T; Yamada Y
    Biochem Biophys Res Commun; 2008 Sep; 374(2):382-7. PubMed ID: 18639523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two decades of cancer genetics: from specificity to pleiotropic networks.
    Grisendi S; Pandolfi PP
    Cold Spring Harb Symp Quant Biol; 2005; 70():83-91. PubMed ID: 16869741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into the nucleophosmin/nucleoplasmin family of nuclear chaperones.
    Frehlick LJ; Eirín-López JM; Ausió J
    Bioessays; 2007 Jan; 29(1):49-59. PubMed ID: 17187372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional genetics and experimental models of human cancer.
    Zhao JJ; Roberts TM; Hahn WC
    Trends Mol Med; 2004 Jul; 10(7):344-50. PubMed ID: 15242683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human RNA polymerase II-associated factor complex: dysregulation in cancer.
    Chaudhary K; Deb S; Moniaux N; Ponnusamy MP; Batra SK
    Oncogene; 2007 Nov; 26(54):7499-507. PubMed ID: 17599057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.